Arimoclomol (citrate), CAS 368860-21-3

Product Description: Arimoclomol citrate (BRX-220 citrate) is an orally active co-inducer of heat shock proteins (HSP)[1]. Arimoclomol citrate protects motor neurons by enhancing Hsp expression, thus directly affecting protein aggregation and clearance of misfolded assemblies via the proteasome-ubiquitin system[2]. Arimoclomol citrate can be used for the study of Niemann–Pick disease type C.

Applications: Metabolism-protein/nucleotide metabolism

Formula: C20H28ClN3O10

References: [1]Rakonczay Z Jr, et al. Nontoxic heat shock protein coinducer BRX-220 protects against acute pancreatitis in rats. Free Radic Biol Med. 2002 Jun 15;32(12):1283-92./[2]Phukan J. Arimoclomol, a coinducer of heat shock proteins for the potential treatment of amyotrophic lateral sclerosis. IDrugs. 2010 Jul;13(7):482-96.

CAS Number: 368860-21-3

Molecular Weight: 505.90

Compound Purity: 99.76

Research Area: Metabolic Disease; Inflammation/Immunology; Neurological Disease

Solubility: DMSO : 35 mg/mL (ultrasonic)

Target: HSP

• Artikelnummer: MEXHY-106443B-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-106443B-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK